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Abstract: Objective 
 
To assess reliability and discriminative validity of cartilage 
compositional magnetic resonance imaging (MRI) in knee osteoarthritis 
(OA). 
 
Design 
 
The study was carried out per PRISMA recommendations. We searched MEDLINE 
and EMBASE (1974 - present) for eligible studies. We performed 
qualitative synthesis of reliability data. Where data from at least 2 
discrimination studies were available, we estimated pooled standardized 
mean difference (SMD) between subjects with and without OA. 
Discrimination analyses compared controls and subjects with mild OA 
(Kellgren-Lawrence (KL) grade 1-2), severe OA (KL grade 3-4) and OA not 
otherwise specified (NOS) where not possible to stratify. We assessed 
quality of the evidence using QAREL and QUADAS-2 tools. 
 
Results 
 
Fifty-eight studies were included in the reliability analysis and 25 
studies were included in the discrimination analysis, with data from a 
total of 1,989 knees. Intra-observer, inter-observer and test-retest 
reliability of compositional techniques were excellent with most 
intraclass correlation coefficients > 0.8 and coefficients of variation < 
10%. T1rho and T2 relaxometry were significant discriminators between 
subjects with mild OA and controls, and between subjects with OA (NOS) 
and controls (p < 0.001). T1rho showed best discrimination for mild OA 
(SMD [95% CI] = 0.73 [0.40 to 1.06], p < 0.001) and OA (NOS) (0.60 [0.41 
to 0.80], p < 0.001). Quality of evidence was moderate for both parts of 
the review. 
 
Conclusions 
 
Cartilage compositional MRI techniques are reliable and, in the case of 
T1rho and T2 relaxometry, can discriminate between subjects with OA and 
controls.  
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ABSTRACT 
Objective 
To assess reliability and discriminative validity of cartilage compositional magnetic 
resonance imaging (MRI) in knee osteoarthritis (OA). 
Design 
The study was carried out per PRISMA recommendations. We searched MEDLINE and 
EMBASE (1974 – present) for eligible studies. We performed qualitative synthesis of 
reliability data. Where data from at least 2 discrimination studies were available, we 
estimated pooled standardized mean difference (SMD) between subjects with and 
without OA. Discrimination analyses compared controls and subjects with mild OA 
(Kellgren-Lawrence (KL) grade 1-2), severe OA (KL grade 3-4) and OA not otherwise 
specified (NOS) where not possible to stratify. We assessed quality of the evidence 
using QAREL and QUADAS-2 tools. 
Results 
Fifty-eight studies were included in the reliability analysis and 26 studies were 
included in the discrimination analysis, with data from a total of 2,007 knees. Intra-
observer, inter-observer and test-retest reliability of compositional techniques were 
excellent with most intraclass correlation coefficients > 0.8 and coefficients of 
variation < 10%. T1rho and T2 relaxometry were significant discriminators between 
subjects with mild OA and controls, and between subjects with OA (NOS) and 
controls (p < 0.001). T1rho showed best discrimination for mild OA (SMD [95% CI] = 
0.73 [0.40 to 1.06], p < 0.001) and OA (NOS) (0.60 [0.41 to 0.80], p < 0.001). Quality of 
evidence was moderate for both parts of the review. 
Conclusions 
Cartilage compositional MRI techniques are reliable and, in the case of T1rho and T2 
relaxometry, can discriminate between subjects with OA and controls.  
KEY WORDS 
Knee osteoarthritis; Magnetic resonance imaging; Cartilage composition; Quantitative 
cartilage imaging; Cartilage mapping 
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INTRODUCTION 
Breakdown of articular cartilage is an important feature of knee osteoarthritis (OA). 
The earliest changes in articular cartilage are alterations in the biochemical 
composition of the extracellular matrix (ECM), a network of collagen fibrils and 
glycoproteins. These compositional changes may predispose to the development of 
focal defects, which in turn may lead to more diffuse cartilage loss associated with 
established OA.  
Cartilage compositional MRI techniques such as T1rho relaxometry, T2 relaxometry 
and delayed gadolinium enhanced MRI of cartilage (dGEMRIC) are sensitive to 
changes in cartilage ECM composition, and provide a way to detect degeneration 
before gross morphological changes become apparent.  This contrasts with 
conventional clinical MRI which can detect focal defects and diffuse cartilage loss but 
is limited in its ability to detect earlier changes in cartilage composition. 
Compositional MRI techniques may therefore allow identification of individuals 
suitable for intervention at an earlier stage, before irreversible changes occur. They 
also have the potential to assess response to treatments designed to repair or 
regenerate cartilage or slow degradation1. 
Previous systematic reviews have assessed the reliability and discriminative validity of 
radiographic and conventional clinical MRI assessment of knee osteoarthritis2–4. 
However, there has been no systematic review which has evaluated the reliability or 
discriminative validity of cartilage compositional techniques. This was identified as a 
gap in the literature in recent Osteoarthritis Research Society International (OARSI) 
guidelines for the use of imaging in the setting of OA clinical trials5. 
*Manuscript
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As cartilage compositional MRI techniques grow in popularity it is important to 
understand how reliable the techniques are and how well they can distinguish cartilage 
in individuals with OA compared to cartilage in healthy controls. Accordingly, the aim 
of this study was to assess the reliability and discriminative validity of cartilage 
compositional MRI in knee osteoarthritis. 
For the purposes of this review, we use the term “reliability” to encompass both 
repeatability (measurement precision with conditions remaining unchanged between 
repeat measurements e.g. same observer, same MR platform) and reproducibility 
(measurement precision with conditions changing between repeat measurements, e.g. 
change in observer, change in MR platform) as defined by the Radiological Society of 
North America Quantitative Imaging Biomarkers Alliance (RSNA-QIBA) Metrology 
Working Group6. 
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METHODS 
This systematic review and meta-analysis undertaken in accordance with the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
recommendations7. 
Protocol & Registration 
The study review protocol was prospectively registered on PROSPERO, the 
international prospective register of systematic reviews (available at 
www.crd.york.ac.uk/prospero/display_record.asp?ID=CRD42016045250). 
Eligibility criteria 
We considered in-vivo studies in human subjects involving at least one cartilage 
compositional MRI technique at the knee. The list of compositional techniques 
considered included, but was not limited to, T1rho relaxometry, T2 relaxometry, T2* 
relaxometry, delayed gadolinium enhanced MRI of cartilage (dGEMRIC), sodium 
imaging, glycosaminoglycan chemical exchange saturation transfer imaging 
(gagCEST), diffusion weighted imaging (DWI) and diffusion tensor imaging (DTI). For 
a study to be included, it needed to provide reliability data on the technique used 
(either in subjects with OA or healthy controls or both) or provide measurements 
comparing subjects with OA to a control group (i.e. discrimination data), or provide 
both reliability and discrimination data. We considered only full-text papers reporting 
original data. Conference abstracts, review papers, letters to the editor and opinion 
pieces were excluded. We limited included studies to those published in English. 
Studies using animal models or human tissues ex-vivo were excluded. 
Information sources 
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We searched MEDLINE (1946 – February 2017) and EMBASE (1974 – February 2017) via 
OVID.  We also searched the databases OpenGrey, Clinicaltrials.gov and the World 
Health Organization (WHO) International Clinical Trials Registry for additional 
studies.  The search strategy for the OVID search is presented in the Supplemental 
Material. We further scrutinized the reference lists of full-text manuscripts obtained, 
personal databases and the contents tables of key journals for any omitted studies.  
Study selection 
Two researchers performed initial screening to identify potentially eligible studies per 
inclusion and exclusion criteria. The full-texts of all potentially eligible papers were 
then evaluated to enable a final decision on inclusion. Discrepancies were resolved by 
discussion between the reviewers. 
Data extraction and list of items 
Data extraction was performed by a single researcher using a piloted electronic data 
collection form and subsequently verified by a second researcher, with disagreements 
resolved by discussion. Where a study was considered potentially eligible but data 
were not presented in an extractable format (e.g. presented in a figure without raw 
values), the corresponding study author was contacted by email to attempt to obtain 
the relevant data. 
Data extracted for all studies included the following: year of publication, number of 
participants, age and sex of participants, study design, definition of OA used by the 
study (if applicable), details of the MR acquisition protocol, MR field strength, 
experience and training of image analysts, blinding of image analysts to additional 
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clinical information (e.g. OA/control status) and type of regional or subregional 
analysis performed.  
We divided study participants with OA into those with mild OA (Kellgren-Lawrence 
(KL) grades 1-2), severe OA (KL grades 3-4) or OA not otherwise specified (NOS) when 
the study did not provide the information required to stratify8. 
Risk of bias in primary studies 
The risk of bias for studies of reliability was performed by a single reviewer using a 
modification of the Quality Appraisal of Diagnostic Reliability (QAREL) tool relevant 
to our analysis9.  Assessment of risk of bias in studies of discriminative validity was 
performed using a modification of the revised Quality Assessment of Diagnostic 
Accuracy (QUADAS-2) tool10. Full details of the modifications made to QAREL and 
QUADAS-2 tools are presented in the Supplemental Materials 
Data analysis 
The primary endpoint for the reliability assessment was a narrative summary of the 
reliability statistics for intra and inter-observer and test-retest reliability. 
A meta-analysis was not appropriate due to the heterogeneity in methods for 
calculating reliability metrics from the included studies. For example, the coefficient of 
variation (CV) may be presented as a single value, or the root-mean-square average of 
several values (RMSCV). There are numerous approaches to computing the intraclass 
correlation coefficient (ICC) which prevent pooling, and directly comparing ICC across 
different populations could be misleading11,12. For the purposes of our review we used 
an interpretation of ICC values based on Landis and Koch13. 
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The primary endpoints for the discriminative validity part of this review were estimates 
of standardized mean difference (average difference between groups divided by the 
pooled standard deviation of the two groups, analogous to effect size) between 
subjects with OA and normal controls for each compositional technique studied. 
Secondary endpoints were estimates of standardized mean difference between subjects 
with OA and normal controls for each compositional technique studied, limited to 
studies where control group participant age had been matched to the OA group. We 
used the standardized mean difference to allow comparison across different 
compositional techniques with values which vary considerably in magnitude. Where 
there were less than two studies available for any given comparison, a narrative 
analysis was conducted. 
We assessed the appropriateness for meta-analysis by assessing the data extraction 
table for study heterogeneity in cohort characteristics, imaging technique, analysis 
technique and study processes. Where study heterogeneity was evident for one or 
more of these factors, a narrative analysis was undertaken. When this did not occur, a 
meta-analysis was undertaken. In each analysis, statistical heterogeneity was 
calculated through the I2 statistic. Fixed effects models were used to pool outcome 
measures with low heterogeneity (I2 ≤ 10%), whereas random effects models were used 
to pool outcome measures with high heterogeneity (I2 > 10%). We used a strict I2 
threshold as we wished to minimize the risk of any ‘unknown’ heterogeneity from 
influencing the interpretation of our analyses, particularly as we placed emphasis on 
excluding ‘known’ heterogeneity in our assessment of study characteristics. 
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All meta-analyses were performed using Review Manager version 5.3 (The Cochrane 
Collaboration)14. 
[FIGURE 1]  
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RESULTS 
Study selection 
Database searching identified 665 citations, with an additional 79 citations identified 
through other sources (personal databases, reference lists of included studies, contents 
tables of key journals). The full-text version of 192 articles was retrieved for detailed 
review. Forty-eight articles were included in the reliability assessment, 16 articles were 
included in the discrimination validity assessment and 10 articles were included in 
both evaluations (Figure 1)15–88. 
Reliability study characteristics 
Characteristics of included studies are reported in Table 1. Data from 1,473 subjects 
were included in the reliability analysis. The most commonly used compositional 
technique was T2 relaxometry, featuring in 36 of 58 (62%) studies. The number of 
participants in each study ranged from five to 289 (median 20). The mean (standard 
deviation, SD) age of participants was 46.2 (14.5) years. Fifty-three percent of included 
subjects were female.  
[TABLE 1]  
Discriminative validity study characteristics 
Characteristics of included studies are reported in table 2. Data from 766 subjects were 
included in the discriminative validity analysis. The most commonly used 
compositional technique was T2 relaxometry, featuring in 17 of 26 (65%) studies. The 
number of participants in each study ranged from 15 to 152 (median 33). The mean (SD) 
age of OA subjects was 58.3 (4.9) years compared to 40.9 
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 (11.7) years in control subjects with females representing 56% of OA subjects 
compared to 52% of controls.  Eight studies included subjects with mild OA, three 
studies included both subjects with mild OA and subjects with severe OA and 15 
studies did not stratify OA severity and were considered as OA (NOS) for our analyses.  
[TABLE 2]  
Risk of bias in primary studies 
Full results of quality assessments of reliability and discriminative validity studies are 
presented in the Supplemental Materials. Overall, the quality of the evidence was 
moderate for the reliability assessment and moderate for the discriminant validity 
assessment. Recurrent weaknesses for the reliability data included the assessment of 
reliability in only healthy volunteer subjects, lack of information regarding image 
analyst experience or training, and lack of information regarding image analyst 
blinding to previous results for studies of intra and inter-observer reliability. Recurrent 
weaknesses for the discrimination validity data included the use of unmatched control 
subjects and the potential lack of blinding of image analysts to subject group. 
Reliability outcomes 
The results of the reliability analysis are presented in Table 1 and Figure 2.  
1. T2 relaxometry 
Intra-observer ICCs ranged from 0.30 to 0.99 and CVs ranged from 0.8 to 4.7%. Studies 
featuring multiple subregional analyses tended to report lower ICC values 65.  Inter-
observer ICCs ranged from 0.17 to 0.99 and CVs ranged from 1.0 to 12.2%. Again, 
studies which performed analysis on multiple small subregions and analysis of multiple 
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cartilage layers had poorer agreement26,65. CVs for test-retest reliability where analyses 
were performed on major compartments (e.g. medial femur, medial tibia etc) were 2.3 
to 6.5%, with higher values (up to 22%) again seen where smaller subregional or 
laminar analyses were performed26. Three studies examined test-retest reliability in a 
multi-center setting, reporting CVs between 2.3 and 5.3% for major compartments and 
up to 14% for subregional analyses16,39,45. 
2. T1rho relaxometry 
One study provided intra-observer reliability data, with a CV of 3.8%32. All studies of 
inter-observer reliability reported ICC values in the ‘excellent’ range (> 0.8). Inter-
observer CV values ranged from 1.4 to 11.8%. Test-retest reliability was good-to-
excellent (ICCs 0.73 to 0.96, CV 2.3 to 6.1%) when major compartments were analysed 
but poorer (ICCs as low as 0.2, CV as high as 19%) in two studies where laminar 
analysis was performed20,45. Two studies examined test-retest reliability in a milti-
center setting, reporting a CVs of 4.9% for major compartments and up to 18.8% for 
subregional analyses39,45. 
3. dGEMRIC 
Intra- and inter-observer reliability data were reported by two studies each, with 
excellent agreement (ICCs > 0.9) and CVs of less than 3%15,48,67.  Test-retest reliability 
was excellent (ICCs > 0.85, CV 4.2 to 7.4%) apart from one study comparing different 
T1 mapping techniques for dGEMRIC which reported ICC values as low as 0 and a CV 
of 11% for a variable flip angle (VFA) technique61. 
4. Others 
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Intra- and inter-observer reliability data were also reported for sodium imaging, 
gagCEST, T2* relaxometry, T1 relaxometry (without contrast), magnetization transfer 
(MT) imaging and ultrashort TE T2* (UTE-T2*) relaxometry, with excellent agreement 
(ICCs > 0.8) for gagCEST, T2*, MT and UTE-T2*, CVs of 5.1 to 5.9% for T1 mapping and 
CVs of 8.1 to 11.4% for sodium imaging. 
Test-retest reliability data were reported for the above techniques as well as DTI. 
Excellent test-retest reliability ICCs were demonstrated for T2* (0.93) and sodium 
imaging (0.91)49,50.  Test-retest CVs were generally less than 10% except for sodium 
imaging which had test-retest CVs between 9.1 and 12.3%32,43. 
[FIGURE 2] 
Synthesis of results – discriminative validity 
Results of the meta-analysis of discriminative validity are presented in Table 3 and 
Figure 3. Individual forest plots are presented in the Supplemental Materials.  
1. Mild OA 
Both T2 and T1rho relaxometry demonstrated significant discrimination between 
subjects with mild OA and controls (p < 0.001), with a greater standardized mean 
difference (SMD) for T1rho (0.73, 95% CI 0.40 to 1.06) than for T2 (0.49, 0.30 to 0.67). 
dGEMRIC did not show significant discrimination for mild OA with a SMD of 0.13 
(95% CI -0.23 to 0.49, p = 0.47). Single studies evaluating MT imaging in patellar 
cartilage and DTI imaging did discriminate significantly between subjects with mild 
OA and controls in some compartments56,62. 
2. Severe OA 
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Pooling of discrimination data was possible for T2 relaxometry only, which 
demonstrated significant discrimination between subjects with severe OA and controls 
(p < 0.001) with, as expected, a greater SMD of 1.24 (0.63 to 1.85) when compared to the 
mild OA data. Single studies evaluated discrimination validity for T1rho, dGEMRIC and 
MT, demonstrating significant differences between groups for T1rho and dGEMRIC but 
not MT. 
3. OA (Not Otherwise Specified) 
T2 relaxometry and T1rho relaxometry demonstrated significant differences between 
subjects with OA (NOS) and controls (p < 0.001). As for mild OA subjects, T1rho 
relaxometry had a higher SMD (0.60, 0.41 to 0.80) than T2 relaxometry (0.48, 0.34 to 
0.62). dGEMRIC (p = 0.18, SMD = -0.31, -0.78 to 0.15) and sodium imaging (p = 0.17, 
SMD = -0.20, -0.50 to 0.09) did not significantly discriminate OA subjects from 
controls. Single studies of T2* relaxometry and DTI demonstrated significant 
discrimination in some compartments49,57. 
4. Additional analyses 
When we restricted our analysis to studies that had control groups matched to OA 
subjects for age, we could pool data for T2 and T1rho relaxometry comparing OA 
(NOS) subjects with controls. Both techniques retained significant discrimination 
between subjects with OA and controls (p < 0.001), but with lower SMD values of 0.32 
(0.20 to 0.44) for T2 and 0.34 (0.17 to 0.51) for T1rho. 
[TABLE 3]  
[FIGURE 3]  
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DISCUSSION 
This systematic review has shown that cartilage compositional MRI techniques 
perform well across the domains of intra-observer, inter-observer and test-retest 
reliability. T2 and T1rho relaxometry demonstrated discrimination validity in mild OA 
and non-specific OA populations.  
Reliability values were generally high across all techniques studied with ICC values in 
the ‘excellent’ range (> 0.8) and low CVs (< 5% in most cases). Reliability was slightly 
poorer for sodium imaging. This is probably explained by the fact that the images 
being analyzed are of lower signal-to-noise ratio (SNR) than proton images. The 
reliability values here are commensurate with those for established quantitative 
measures of joint structure such as cartilage volume and quantitative imaging 
biomarkers in other body systems2,89,90. This suggests that cartilage compositional MRI 
is suitably reliable for use in the assessment of knee OA, particularly for the techniques 
of T2 and T1rho relaxometry where there are most data available.  Analyses performed 
on small cartilage subregions or involving laminar analysis (where cartilage is split into 
2 or 3 layers from deep to superficial) tended to be less reliable than those assessing 
larger cartilage regions.  This is probably due to the effects of noise and partial volume 
with adjacent synovial fluid and subchondral bone which are likely to be exacerbated 
in small regions of interest (ROIs), together with increased scope for subjective 
positioning differences between observers. This should be borne in mind when such 
analyses are interpreted. Few studies examined test-retest reliability in a multi-center 
setting. To facilitate use of compositional techniques in large-scale clinical trials, more 
studies in this area are needed. 
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T1rho and T2 relaxometry demonstrated the ability to discriminate between subjects 
with mild OA and controls, and subjects with OA (NOS) and controls. T1rho 
demonstrated larger SMD values in both populations suggesting that it has superior 
discrimination validity, in keeping with the results of previous in vivo and ex vivo 
studies66,84,91. dGEMRIC and sodium imaging demonstrated smaller and non-
significant SMDs between OA subjects and controls. This is contrasts with previous 
work showing better correlation between dGEMRIC and glycosaminoglycan (GAG, the 
main polysaccharide side chains of the proteoglycan molecules) content of articular 
cartilage than between T1rho values and GAG content92.  Possible reasons for the 
poorer performance of dGEMRIC in this meta-analysis include variation in imaging 
protocols between studies which may have affected results9392.  
For all techniques studied, there was significant statistical heterogeneity between 
different cartilage regions. This concurs with previous work demonstrating significant 
spatial variation in articular cartilage compositional values at the knee, and potentially 
suggests that changes in cartilage composition due to OA also show substantial spatial 
variation70,76,94. 
The principal role for cartilage compositional MRI is the detection of adverse changes 
in cartilage composition prior to morphological damage. Therefore, they are of greatest 
potential utility in subjects with mild OA and are of questionable value once the 
disease is more advanced95. SMD values for T1rho and T2 relaxometry, which showed 
significant discrimination validity for mild OA population, correspond to relatively 
small absolute differences between mild OA subjects and controls of 3.5 ms (95% CI 1.9 
– 5.2 ms) for T1rho and 1.9 ms (1.2 – 2.7 ms) for T2. Although statistically significant 
differences have been demonstrated between groups in this meta-analysis, it is 
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questionable whether these differences are of of clinical significance, that is of 
sufficient magnitude to provide useful clinical discrimination when interpreting a 
single measurement.  Moreover, these small differences may be exaggerated because 
few control groups were matched to OA subjects for important characteristics such as 
age or sex.  
This study has some unavoidable limitations. First, we have considered reliability and 
discrimination validity of cartilage compositional MRI, but not responsiveness to 
change. This will be an important factor to consider when using cartilage 
compositional MRI as an imaging biomarker of response to treatment, and from a 
clinical utility point of view it may be that the magnitude of intra-subject change is 
more important than absolute mean differences between OA and control groups. 
However, at present, there have not been sufficient studies in this area to permit 
pooled analysis.  Moreover, the majority of studies which have used cartilage 
compositional MRI in a longitudinal setting do not report sufficient data to allow 
calculation of standardized response means for pooling. Second, the quality of 
included studies was variable for both reliability and discriminative validity studies. 
The reliability values reported across different studies were consistent suggesting that 
substantial bias affecting the results of this part of the review had not been introduced 
by these factors. However, discriminative validity results did vary between studies, as 
indicated by moderate heterogeneity in the meta-analyses.  
In conclusion, this systematic review and meta-analysis has demonstrated that 
cartilage compositional MRI techniques are reliable and, in the case of T2 and T1rho 
relaxometry, able to discriminate between subjects with OA and controls.  
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 FIGURE CAPTIONS 
Figure 1. PRISMA flow chart demonstrating process for selection of included studies. 
Figure 2. Summary of reliability data (top panel – coefficient of variation (%), bottom 
panel – intraclass correlation coefficient) for the three most commonly studied 
compositional technique. Central point represents median value, lines represent 
ranges. Where a study provided more than one estimate, a mean value is used. 
Figure 3. Summary forest plot comparing standardized mean differences between 
subjects with and without OA for each technique where pooling of data was possible. 
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 TABLES 
Table 1 - Characteristics of included reliability studies 
 
 
Study Number of OA 
subjects 
Number 
of other 
subjects 
Mean age Gender (% 
female)  
MRI field 
strength 
(T) 
Compositional 
techniques 
used 
Type of 
reliability 
assessed 
Reliability 
statistic** 
Reliability 
value 
Assessors 
 mild sev NOS  OA other OA other Number Experience 
Anandacoomarasamy15 - - - MN - NS - NS O dGEMRIC intraO ICC N.QR R NS 
Balamoody16 - - RM - TQ - MU - O TM TR# RMSCV M.O – Y.O R NS 
Baum17 - - - RMY - UN - UN O TM intraO RMSCV R.[Y R NS 
Blumenkrantz18 RO R[ - - YT - OQ - R.U TM intraO CV R.U – M R NS 
Bron19 - - RR RN UM M[ YT TN O dGEMRIC TR ICC N.`U – N.Q R NS 
Carballido-Gamio20 - - - U - MQ - MN O TRrho TR CV O.` – RM.O† NS NS 
Dardzinski21 - - U U UM [N O TM TR RMSCV O.O – Y.U R NS 
Duryea22 - - - RN - OO - UN O TM 
intraO 
CV R.O 
R NS 
ICC N.QQ 
TR 
CV U.` 
ICC N.QM 
Guha23 - - MN MN U` UT UN YN O DTI TR RMSCV Y.U – RR.Y NS NS 
Gupta24 - - - MN - O[ - OU O TRrho interO 
RMSCV O.Q 
M NS 
ICC N.QY 
Hada25 UN - - RQ U[ MU UT O[ O TM 
intraO ICC N.QR 
M NS 
interO ICC N.`[ 
Hannila MNNQ26 - - - MN - MO - UN R.U TM interO 
RMSCV R.` – RT.M† 
M NS 
ICC N – N.Q`† 
Hannila MNRU27 - - - Q - ON - TT R.U TM TR 
RMSCV M.U – MM.M† 
R NS 
ICC N – N.Q`† 
Hesper28 - - - RN - MQ - [N O TM* intraO ICC N.Q[ R ` years 
 Study Number of OA 
subjects 
Number 
of other 
subjects 
Mean age Gender (% 
female)  
MRI field 
strength 
(T) 
Compositional 
techniques 
used 
Type of 
reliability 
assessed 
Reliability 
statistic** 
Reliability 
value 
Assessors 
 mild sev NOS  OA other OA other Number Experience 
Holtzman29 - - - MY - OY - O` O 
TRrho 
interO CV 
T.O 
M At least MU datasets TM T.Q 
Hovis MNRR30 - - - RYR - UN - UQ O TM intraO RMSE N.[T – R.UR R NS 
Hovis MNRM31 - - RNU - YU - Y` - O TM 
intraO 
ICC 
N.QQ 
M NS 
interO N.QQ 
Jordan32 - - - ` - M` - MU O 
TRrho 
intraO 
RMSCV 
O.` 
M NS 
interO U.[ 
TR T.Y – Y.R 
TM 
intraO T.[ 
interO Y.[ 
TR Y.O – RN.[ 
Sodium 
intraO `.R 
interO RR.T 
TR RR.O – RM.Q 
Joseph MNRR33 - - - RTU - UN - UQ O TM intraO RMSCV N.Q – M.R R NS 
Joseph MNRM34 - - - M`Q - UR - T[ O TM intraO RMSCV N.` – O.M R NS 
Juras MNRY35 - - - MO - OO - U[ O TM interO CV U.` – RN.`† M RN years/ RU years 
Koli36 `N - - - U` - RNN - R.U TM interO RMSCV M NS NS 
X Li MNNU38 - - Q RN UM ON TT TN O TRrho TR CV T.` NS NS 
X Li MNRT37 - - - Y - MM-OU - UN O 
TRrho 
TR RMSCV 
T.M – Y 
NS NS 
TM U – Y.O 
X Li MNRU39 - - - R` - NS - NS O 
TRrho 
TR# RMSCV 
M.O – U.R 
NS NS 
TM O.M – U.O 
Liebl40 - - - RON - UQ - YN O TM 
intraO 
RMSCV 
R.[ 
M NS 
interO R.Y 
Liess41 - - - MN - M` - MN R.U TM TR CV R.[ NS NS 
Liu42 - - RT RO UO M` OY MO O TM TR CV O.R - RN R T years 
 Study Number of OA 
subjects 
Number 
of other 
subjects 
Mean age Gender (% 
female)  
MRI field 
strength 
(T) 
Compositional 
techniques 
used 
Type of 
reliability 
assessed 
Reliability 
statistic** 
Reliability 
value 
Assessors 
 mild sev NOS  OA other OA other Number Experience 
Madelin43 - - - Y  O[ - UN O, [ Sodium TR RMSCV Q.R – RM.O NS NS 
Matsubara44 RN - - RQ U[ OQ OM N O TRrho interO ICC N.QO M ` years/ Q years 
Mosher MNRR45 RY RY - R` UT M[ UQ Y[ O 
TRrho 
TR# 
ICC N.MN – N.QO† 
NS NS 
TRrho RMSCV [.MO – R`.`O† 
TM ICC N.YR – N.Q`† 
NS Computer tutorial TM RMSCV T.OY – RT† 
Mosher MNNT46 - - - ON - MM-`Y - RNN O TM intraO wK N.[[ R ` years 
Multanen MNRU48 [` - - RM UQ U` RNN RNN R.U 
TM 
interO RMSCV 
M 
M Y years/ RM years dGEMRIC O 
Multanen MNNQ47 - - - RN - OM - UN R.U dGEMRIC TR 
ICC N.TU – N.Q`† 
NS NS 
RMSCV T.[ – RM. Q† 
Newbould MNRM49 - - RO U YT YM [[ `N O TM* TR 
ICC N.[ – N.QT 
NS NS 
CV O.M – [.[ 
Newbould MNRMb50 - - RU U YT YM `N `N O Sodium TR 
ICC N.Y[ – N.QT 
R NS 
CV O.Y – Q.Q 
Nishioka MNRM51 - MN - - [[ - QN - O 
TRrho 
interO CV 
< Y 
NS NS 
TM < Y 
Nishioka MNRU53 - - [` - YQ - [[ - O 
TRrho 
interO RMSCV 
RR.` 
M NS 
TM RM.M 
Nishioka MNRO52 - - - O[ - MO - UQ O 
TRrho 
interO RMSCV 
R.T 
M NS 
TM R.N 
Pan54 - - - QU - UU - YR O TM intraO RMSCV R.R – R.M R NS 
Pedoia55 TN - - RU UT T` NS NS O TRrho TR CV M M M years/ T years 
Raya MNRT56 U - - RN YY OR NS ON [ DTI TR RMSCV M.Q – U.Y NS NS 
Raya MNRM57 - - RN RY YR OR UN TT [ 
DTI 
TR RMSCV 
[.O – RQ.O† 
R U years 
TM U.U – Y.Q† 
 Study Number of OA 
subjects 
Number 
of other 
subjects 
Mean age Gender (% 
female)  
MRI field 
strength 
(T) 
Compositional 
techniques 
used 
Type of 
reliability 
assessed 
Reliability 
statistic** 
Reliability 
value 
Assessors 
 mild sev NOS  OA other OA other Number Experience 
Schleich58 - - - MN - MU - TN O gagCEST 
intraO 
ICC 
N.QU R ` years 
interO N.QU M U years/ ` years 
Serebrakian59 - - - RM[ - UU - UY O TM 
intraO 
RMSCV 
R.R 
M NS 
interO O.O 
Singh60 - - - ` - MN-OU - NS [ TRrho TR 
ICC N.[O – N.QY 
NS NS 
CV M.O – T.O 
Siversson61 - - - Q - TU - UY R.U dGEMRIC TR 
ICC N – N.YQ 
NS NS 
RMSCV Y.N – RR.Y 
Sritanyaratana62 RR - - MN UO OM OY MU O MT TR CV N.U – T.Y R NS 
Stehling MNRN64 - - - RMN - UR - UN O TM intraO CV R.M R NS 
Stehling MNRR63 - - - RN - UM - UN O TM interO RMSCV R.M – M.`† M NS 
Surowiec65 - - - R` - R`-OU - NS O TM 
intraO 
ICC 
N.R[ – N.`Q 
O 
U years/ Y 
years/ RO 
years interO N.O – N.QY 
Takayama66 - RY - - [O - `` - O 
TRrho 
interO ICC 
N.`R 
M RM years / [ years TM N.QM 
Tiderius67 - - - RM - MT - N R.U dGEMRIC 
intraO 
CV 
R.U – M.Y 
Y 
M medical 
students, M 
ortho 
surgeons, M 
radiologists 
interO R.` 
Van Tiel68 R[ - - - UN - TR - O dGEMRIC TR ICC N.`[ – N.QU R Medical degree 
 Study Number of OA 
subjects 
Number 
of other 
subjects 
Mean age Gender (% 
female)  
MRI field 
strength 
(T) 
Compositional 
techniques 
used 
Type of 
reliability 
assessed 
Reliability 
statistic** 
Reliability 
value 
Assessors 
 mild sev NOS  OA other OA other Number Experience 
Welsch69 - - - R[ - MY - MT O, [ 
TM 
interO ICC N.QR – N.QU† 
O 
M years/ RN 
years/ MU 
years 
TR CV [.M – `.[† 
TM* 
interO ICC N.`` – N.QN† 
TR CV Y.` – [.`† 
MT 
interO ICC N.`T – N.QR† 
TR CV Q.M – RN.`† 
Wiener70 - - - MU - OR - YN R.U TR TR CV U.R – U.Q R NS 
Williams71 - - - RR - M` - RNN O UTE-TM* 
intraO ICC N.`N – N.Q[† 
R Q years 
TR RMSCV Y - RY† 
Zuo72 - - - Y - M[-ON - R[ O 
TRrho 
TR CV 
R.` – U.Y 
NS NS 
TM M.Q – U.[ 
 
Abbreviations: sev  - severe, NS – not specified, intraO – intra-observer, interO – inter-observer, TR – test-retest. 
**Reliability values are presented as ranges when values were provided separately for different cartilage ROIs. RMSCV and CV values are provided as 
percentages. 
†Laminar (e.g superficial/deep cartilage layers) analysis performed. 
# Multicenter study
 Table 2 - Characteristics of included discrimination studies 
 
 
Study Number of OA 
subjects 
Number 
of 
control 
subjects 
Mean age Gender (% female)  MRI field 
strength (T) 
Compositional 
techniques used 
Definition of OA 
 mild sev NOS  OA control OA control 
Dunn73 MN M` - [ YO/Y[* O` YU/UN* TO R.U TM Radiographs and symptoms 
Eckstein74 - - [[ [U U` UU RNN RNN O TM, dGEMRIC Radiographs only 
Hada25 UN - - RQ U[ MU UT O[ O TM ACR criteria 
X Li MNNU38 - - Q RN UM ON TT TN O TRrho Radiographs and/or symptoms 
X Li MNN[77 - - RN RY UY TR ON UN O TRrho, TM Radiographs and symptoms 
X Li MNNQ76 - - RN RN UY TR ON TN O TRrho, TM Radiographs and symptoms 
W Li MNRN75 - - RT Q YM MQ [T YT R.U dGEMRIC MRI and/or radiographs and/or symptoms 
Liu MNRU42 - - RT RO UO M` OY MO O TM Radiographs and symptoms 
Madelin78 - - M` RQ YT OU U[ TM [ Sodium ACR criteria 
Matsubara44 RN - - RQ U[ OQ OM N O TRrho Radiographs and symptoms 
Mosher45 RY RY - R` UR/U[* M[ TT/[U* Y[ O TRrho, TM Radiographs only 
Multanen48 [` - - RM UQ U` RNN RNN R.U TM, dGEMRIC Radiographs and symptoms 
Newbould MNRM49 - - MN R[ YT YR YU [Y O TM* ACR criteria 
Newbould MNRO86 - - M` MO YO YM NS NS O Sodium ACR criteria 
Owman79 - - M[ [ NS NS NS NS R.U dGEMRIC Radiographs only 
 Study Number of OA 
subjects 
Number 
of 
control 
subjects 
Mean age Gender (% female)  MRI field 
strength (T) 
Compositional 
techniques used 
Definition of OA 
 mild sev NOS  OA control OA control 
Raya MNRM57 - - RN RY YR OR UN TT [ DTI, TM ACR criteria 
Raya MNRT56 U - - RN YY OR NS ON [ DTI ACR criteria 
Souza MNRO81 - - TT RQ U[ OQ NS NS O TRrho, TM Radiographs and symptoms 
Souza MNRT80 - - TT QO U[ UN YR U` O TRrho, TM Radiographs and symptoms 
Sritanyaratana62 RR - - MN UO OM OY MU O MT Radiographs and symptoms 
Stahl MNN[82 - - ` RN UY U` RNN RNN O TM Radiographs and symptoms 
Stahl 200983 R[ - - MN UT OT UO UN O TRrho, TM ACR criteria 
Wang84 RN - - RN YU OY MN TN O TRrho, TM Radiographs only 
Wirth85 OM - - `Q YN UU UY YN O TM Radiographs only 
Wyatt86 - - RM [ UQ UN TM [R O, [ TRrho, TM Radiographs and symptoms 
Yao88 MN MN - RR T`/UU* OQ YU/YN* M[ O TM, dGEMRIC, MT Radiographs and symptoms 
 
Abbreviations: sev - severe, ACR – American College of Rheumatology, NS – not specified. 
*Mean ages and female percentage for mild/severe OA groups provided separately
 Table 3 - Summary of discrimination between subjects with OA and controls for 
included compositional techniques. Only techniques with data available for 
pooling (i.e. at least A studies per comparison) are included in this table. 
 
Compositional 
technique 
 
 
Standardised Mean Difference (FG% CI) 
Mild OA vs 
controls n 
Severe OA vs 
controls n 
OA (NOS) vs 
controls n 
T5 J.KF (J.LJ, J.NO) 6 P.AK (J.NL, P.QG) 7 J.KQ (J.LK, J.NA) 89 
T8rho J.OL (J.KJ, P.JN) ; - - J.NJ (J.KP, J.QJ) = 
dGEMRIC 9.87 (-9.57, 9.;E) 5 - - -9.78 (-9.=6, 9.8F) 7 
Sodium - - - - -9.8E (-9.F5, 9.8F) 7 
n – number of studies pooled for standardised mean difference estimate 
Pooled comparisons in bold were statistically significant (p < 9.9F) 
	
SUPPLEMENTAL MATERIAL 
1.   SEARCH STRATEGY FOR MEDLINE AND EMBASE 
1 exp osteoarthritis/ 
2 osteoarth*.tw. 
3 or/1-2 
4 knee.tw. 
5 exp knee/ 
6 or/4-5 
7 exp magnetic resonance imaging/ 
8 MRI.ti,ab. 
9 magnetic resonance.ti,ab. 
10 or/7-9 
11 map*.tw. 
12 relax*.tw. 
13 T2.tw. 
14 T2*.tw. 
15 T1rho.tw. 
16 T1*.tw. 
17 sodium.tw. 
18 dGEMRIC.tw. 
19 gadolinium.tw. 
20 gadopentetate.tw. 
21 diffusion.tw. 
22 DWI.tw. 
23 DTI.tw. 
24 gagCEST.tw. 
25 collagen.tw. 
26 proteoglycan.tw. 
27 glycosaminoglycan.tw. 
28 composition*.tw. 
29 or/11-28 
30 exp sensitivity/ 
31 exp specificity/ 
32 reliab*.tw. 
33 valid*.tw. 
34 sensitiv*.tw. 
35 specific*.tw. 
36 discim*.tw. 
37 reproduc*.tw. 
38 variab*.tw. 
39 or/30-38 
40 and/3,6,10,29,39 
  
2. QUALITY ASSESSMENT OF RELIABILITY AND DISCRIMINATIVE 
VALIDITY STUDIES 
[SUPPLEMENTAL FIGURE 1] 
 
 
Modified QAREL items as follows: 
1. Was the test evaluated in a sample of subjects who were representative of those 
to whom the authors intended the results to be applied? 
2. Was the test interpreted by analysts who were representative of those to whom 
the authors intended the results to be applied? 
3. Were analysts blinded to the findings of other analysts during the study (only 
inter-observer reliability studies)? 
4. Were analysts blinded to their own prior findings of the test under evaluation 
(only intra-observer reliability studies)? 
5. Were analysts blinded to clinical information e.g. age, sex, OA status (only for 
studies featuring both OA subjects and controls)? 
6. Was the time interval between repeated measurements compatible with the 
stability of the measurement (only test-retest reliability studies)? 
7. Was the MR protocol described reproducibly? 
8. Were appropriate statistical measures of agreement used? 
  
[SUPPLEMENTAL FIGURE 2] 
 
Modified QUADAS-2 items as follows: 
1. Patient selection 
Risk of bias 
Could the selection of patients have introduced bias? 
Signaling question 1: Was an attempt made to match control and OA populations for 
important baseline characteristics (e.g. age, sex)? 
Signaling question 2: Did the study avoid inappropriate exclusions? 
Applicability 
Are there concerns that the included patients do not match the review question? 
2. Index test 
Risk of bias 
Could the conduct or interpretation of the index test have introduced bias? 
Signaling question 1: Were image analysts blinded to additional clinical cues (e.g. age, 
sex, OA status)? 
Signaling question 2: Is the MRI acquisition protocol described in sufficient detail for it 
to be reproduced? 
Signaling question 3: Is the image analysis procedure described in sufficient detail for it 
to be reproduced? 
Applicability 
Is there concern that the index test, its conduct or interpretation differ from the review 
question? 
3. Definition of OA 
Risk of bias 
Signaling question 1: Was the study definition of OA based on clinical symptoms, 
imaging findings or both? Were standard (ACR) criteria applied? 
Applicability 
Is there concern that the definition of OA used differs from the review question? 
4. Flow and timing 
Risk of bias 
Signaling question 1: Were all participants included in the analysis? 
  
3. FOREST PLOTS 
[SUPPLEMENTAL FIGURE 3A] 
[SUPPLEMENTAL FIGURE 3B] 
[SUPPLEMENTAL FIGURE 3C] 
[SUPPLEMENTAL FIGURE 4A] 
[SUPPLEMENTAL FIGURE 4B] 
[SUPPLEMENTAL FIGURE 5A] 
[SUPPLEMENTAL FIGURE 5B] 
[SUPPLEMENTAL FIGURE 6] 
 
  
 
 
	









